Cerrone Gabriele M's Form 4/A amendment
AmendedTiziana Life Sciences LtdTLSA · filed Aug 7, 2026
- Accession no.
- 0001213900-26-086697
- Filed
- Aug 7, 2026, 4:16 PM ET
- Trade date
- Jul 21, 2026
- Filing delay
- 17 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 23, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $41.9K. It was filed 17 days after the trade.
This amendment replaces 0001213900-26-080880 (filed Jul 23, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cerrone Gabriele MCIK 0001139306 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | COMMON STOCK | PPurchaseAcquired | +42,357 | $0.99 | +$41,933.43 | 44,814,587 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
This Form 4/A amends the Form 4 filed on June 23, 2026 solely to correct the date of the earliest transaction and the transaction code associated with this open market purchase. No other reported transactions are affected by this amendment.